← Leaderboards
Thomas Julian Ow
Albert Einstein College Of Medicine, Inc
$852,780
Attributed
$852,780
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $172.3K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$852,780 · 2
By mechanism
K23$516,780 · 1
R03$336,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Recurrence”
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Kevin Navin Sheth · Brigham And Women'S Hospital$10,362,027
- Dale Sandler · Social And Scientific Systems, Inc.$9,632,923
- Zhiyong Yang · Fzata, Inc.$7,816,062
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,152,405
- Phillip W Graham · Research Triangle Institute$7,075,871
Research focus
RecurrenceResponseExperimental StudyMalignant Epithelial CellRadiationPreservationCellsDiagnosisLaboratoriesIn VitroBcl2 GeneMalignant NeoplasmsMutationNeoplastic CellAftercareCdkn2a GeneCisplatinDesignBaseFamilyBcl1 OncogeneInstitutionCancer CellTp53 Gene
Grant awards (5)
A two-pronged âsenolyticâ approach to treatment of oral cavity cancer$168,000
R03 · FY2022 · DE · contact PI
A two-pronged âsenolyticâ approach to treatment of oral cavity cancer$168,000
R03 · FY2021 · DE · contact PI
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma$172,260
K23 · FY2020 · DE · contact PI
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma$172,260
K23 · FY2019 · DE · contact PI
Development of a genetic and molecular prediction model for cisplatin and radiation resistance in head and neck squamous cell carcinoma$172,260
K23 · FY2018 · DE · contact PI